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Abstract
For the historian of science the current international program aimed at mapping and sequencing the
entire human genome can be a bit of a headache. The literature on the Human Genome Project (HGP) is
vast and inadequate; the endeavor itself is complicated, involving many institutions and funding sources
and demanding at least some technical knowledge of molecular genetics, computational biology,
informatics, and medical genetics, not to mention science policy and corporate biotechnology. The
project is indecently contemporary, at best eight years old. Meanwhile, genome project promoters
(genomics scientists, biologists turned journalists, and actual journalists) have been producing instant
histories of the HGP, complete with founding parents and eureka experiences. In these accounts, the
anticipated complete map of the human genome, expected by around 2000, commonly appears as a
critical medical resource that will make it possible for geneticists to understand and cure genetic disease
and, indeed, almost all disease. Such bewitching promises are of course part of an established genre of
political narrative that is presumably not taken too seriously, least of all by those making the claims. But
they have added poignancy to the public debate, as those afflicted with genetic disease or those who fear
their children will be so afflicted long for the DNA translation that will, they hope, end their crossgenerational suffering.
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The ELSI Hypothesis
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For the historian of science the current international program aimed at mapping and

sequencing the entire human genome can be a bit of a headache. The literature on
the Human Genome Project (HGP) is vast and inadequate; the endeavor itself is

complicated, involving many institutions and funding sources and demanding at least

some technical knowledge of molecular genetics, computational biology, informatics, and medical genetics, not to mention science policy and corporate biotechnology. The project is indecently contemporary, at best eight years old. Meanwhile,
genome project promoters (genomics scientists, biologists turned journalists, and ac-

tual journalists) have been producing instant histories of the HGP, complete with
founding parents and eureka experiences. In these accounts, the anticipated complete
map of the human genome, expected by around 2000, commonly appears as a critical

medical resource that will make it possible for geneticists to understand and cure
genetic disease and, indeed, almost all disease. Such bewitching promises are of

course part of an established genre of political narrative that is presumably not taken
too seriously, least of all by those making the claims. But they have added poignancy

to the public debate, as those afflicted with genetic disease or those who fear their
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THE ELSI HYPOTHESIS

children will be so afflicted long for the DNA translation that will, t
their cross-generational suffering.

The historian coming across such a drama may well be tempted to

wait for things to calm down. But there are important problems, problem
suited to the historical sensibility, raised by the HGP. The project is self

historical. Its texts reflect a temporally specific understanding of h

essential and profitable territory. And its social organization mirrors the
tions and tensions of late twentieth-century science between industry, g

academia, and the public, between the United States and Japan, betw
Washington, between physician and patient, and between parent and
All of which is by way of introducing a set of four recent publica

with the HGP that cover a narrow piece of this territory fairly well and

a superficial diversity, leave a much larger piece undisturbed. The pie
that gets most of the attention is the "ethical, legal, and social impli
scientific findings, and the reason for the attention is transparent. The

stitutes of Health (NIH) and the Department of Energy-the primary
cies for genome mapping in the United States-have each set aside 5 pe
genome project budgets to support scholars studying the ethical, leg
implications (commonly abbreviated as ELSI) of the genome project
in 1993 this came to $5 million, and in the last four years the agencies to
spent a total of $20 million on ELSI programs. While $20 million does not buy
much big science, it goes a long way in the world of bioethics and history. Three
of the books reviewed here-those by Kevles and Hood, Annas and Elias, and Yesley-are the products of ELSI funding.
The volume edited by Daniel Kevles and Leroy Hood is probably the best available
general introduction to the HGP. Thirteen contributors-six biologists, seven nonscientists-explore the project in fourteen essays focusing on its history, technology,
medical meaning, and ethical and legal implications. Despite the unfortunate title,
The Code of Codes is not entirely exegesis. Three outsiders-Ruth Cowan, Evelyn
Fox Keller, and Dorothy Nelkin (I suspect gender is a relevant issue here)-provide
critical perspective. Cowan attempts to balance the competing values inherent in the
prenatal testing puzzle; Keller explores the shrinking role of "culture" in contemporary discourse where the self has become a biological entity; and Nelkin looks at
the pervasive power of the test, genetic and otherwise, that defines normalcy in ever
more restrictive terms. Virtually all these essays are clearly written, and some are
riveting as literary and cultural products; two examples are former HGP director
James Watson's manifest destiny explanation of why the project must go on and
Charles Cantor's discussion of sequencing technologies, their costs and their foibles.
This is, then, a useful introduction precisely because it captures both promotional
and critical perspectives on the genome project.
The Kevles and Hood volume might be considered part of the "first generation"
of ELSI projects-the product of the early agenda-setting conferences and speaker
series (circa 1989-1990), which included a suitable mix of scholarly experts and a
broad overview of the issues at hand. The next generation is exemplified by the
volume edited by George Annas and Sherman Elias, which is more focused and more
policy oriented. The essays are intended to provide evidence for the "ELSI hypothesis" that scientific research funding should include support for complementary research in the social sciences. And they do demonstrate the potential contributions of
legal scholars, historians, bioethicists, and others to the cultural phenomenon of the
HGP. Robert Proctor's exploration of the relationship between genomics and eugenics is particularly useful, as is Victor McKusick's straightforward but perceptive
insider's summary of the historical development of human gene mapping. Judith
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Swazey offers advice to scientists (e.g., do not trivialize public concerns) based o

the outcome of the recombinant DNA controversies of the 1970s. Meanwhile, the

legal scholar Patricia King questions the legitimacy of allocating so much public
funding to mapping genes, when improving social and environmental conditions would
have more, and more immediate, effects on human health. Thomas Murray, an ethi-

cist, even asks the social scientists if their attention to the HGP reflects its real

importance or only the availability of heretofore unheard-of amounts of money.

The Canadian volume, edited by Marcel Melangon and Raymond Lambert, features a similar mix of eighteen authors, including legal experts, ethicists, philosophers, and scientists. The genre is familiar: a collection of essays drawn from an
interdisciplinary conference held in 1991, in this case by the Quebec branch of the
Mouvement Universel pour la Responsabilite Scientifique (MURS-Quebec). The focus is explicitly on the international genomics effort, the Human Genome Organization, or HUGO. The essays explore genetic techniques and terminology, the risks
and the potential of genomics research, genetic counseling, genomics and agricultural science, genetics and the legal system, and the role of the popular press in
shaping conceptions of genetic disease. In one essay Bruno LeClerc, Marcel Melangon,

Richard Gagne, and Suzanne Nootens express a certain optimism about the efficacy
of citizen debate in resolving the ethical questions raised by genomics research. They

also suggest that the new eugenics provoked by mapping the human genome will be

more insidious than the historical eugenics because it will focus on medical care, an
argument that has appeared in other forums. The book closes with a transcription of
a wide-ranging debate among the contributors about the responsibilities of scientists,
the meaning of genetic disease, and the problems of social tolerance and difference.
Finally, Michael Yesley's bibliography lists more than 2,600 publications that deal
in some manner with the ethical, legal, and social issues raised by the HGP. This
list is part of a database Yesley is developing, with Department of Energy ELSI
funding, that will eventually be available on-line. Inexplicably, first names or even
first initials of the authors are not listed, so that, for example, the work of Sheila
Faith Weiss on German eugenics appears anonymously interspersed with that of another Weiss (unknown to me) who writes articles such as "Hot Prospect for New
Gene Amplifier" for Science News. The inclusion of historical materials is idiosyncratic: for example, Yesley lists a few popular eugenics texts, of no particular importance, from the 1920s and 1930s; there are hundreds of others from the same era
that are not mentioned. I fear that for the uninitiated this printed bibliography will
be of limited use. Serious students of the HGP may find some helpful listings, but
the materials are not grouped or annotated. Yesley, if queried by e-mail, will do a
computer sort based on topic, author, time period, or any combination of parameters.
I recommend the high-tech approach.
These books join a growing literature on the social meaning of genomics research.
More ELSI-funded work is on the way-including forthcoming volumes from Marc
Lappe and Tim Murphy on justice and the HGP and studies by the sociologist Stephen Hilgartner and the historians Lily E. Kay, Robert Proctor, and William Schneider. And of course, in the interest of full disclosure, there is my own ELSI-funded
study, with Dorothy Nelkin, which explores images of the gene in American popular
culture. What impact will such scholarly studies have on the HGP? From the perspective of some scientists, none at all. In the summer of 1993 ELSI came under
fire when leading genomics scientists complained that it was funding too many academic meetings and not enough work on law and policy formulation. Among those
defending ELSI was Francis Collins, current head of the National Center for Human
Genome Research at the NIH. Meanwhile, Philip Pauly has described ELSI as corporate quality control in the massive biomedical research conglomerate that is the
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HGP. Certainly it is a quality-control divis
dependence of mind, as those who are fu
Energy seem to be perfectly willing to in

funding has not turned its very diverse gran

and sequencing genes.
What the funding has done, however, is
dency to divide the project into "science"

Officially outside the ELSI territory is the m

the human genome a meaningful scientifi
tified this as a question that ELSI grantee
cannot expect an objective assessment of
salary it provides. ELSI is an experiment i
to science studies. Yet it may appeal to lea

precisely because it suggests that scientists i

knowledge is then applied in specific soc
The ELSI program, despite all its good wor
science that have long since ceased to be c
the reason, I would suggest, that historians h

debate.

